Geministatins: new depside antibiotics from the fungus Austroacremonium gemini

Andrew Crombie, John A. Kalaitzis, Rachel Chen, Daniel Vuong, Alastair E. Lacey, Ernest Lacey, Roger G. Shivas, Yu Pei Tan, Nicolau Sbaraini, Yit Heng Chooi, Andrew M. Piggott

Research output: Contribution to journalArticlepeer-review

Abstract

Two new depside antibiotics, geministatins A (1) and B (2), were isolated from the fungus Austroacremonium gemini MST-FP2131 (Sordariomycetes, Ascomycota), which was recovered from rotting wood in the wet tropics of northern Australia. The structures of the geministatins were elucidated by detailed spectroscopic analysis, chemical degradation and comparison with literature values. Chemical degradation of 1 and 2 yielded three new analogues, geministatins C–E (3–5), as well as a previously reported compound dehydromerulinic acid A (6). Compounds 1, 2 and 6 exhibited antibacterial activity against the Gram-positive bacteria Bacillus subtilis (MIC 0.2–1.6 µg mL−1) and Staphylococcus aureus (MIC 0.78–6.3 µg mL−1), including methicillin-resistant S. aureus (MRSA), while 4 exhibited antifungal activity against the yeast Saccharomyces cerevisiae (MIC 13 µg mL−1).

Original languageEnglish
Pages (from-to)639-646
Number of pages8
JournalJournal of Antibiotics
Volume77
Issue number10
Early online date26 Jun 2024
DOIs
Publication statusPublished - Oct 2024

Fingerprint

Dive into the research topics of 'Geministatins: new depside antibiotics from the fungus Austroacremonium gemini'. Together they form a unique fingerprint.

Cite this